June 27th is National PTSD Awareness Day! Post-Traumatic Stress Disorder develops after someone has witnessed or been involved in a traumatic or life-threatening event. Like most mental health disorders, PTSD can make it hard for a person to perform daily tasks. It’s common for those battling the disease to have disrupted sleep, troubling flashbacks, and to feel on edge.
In the United States, 7 or 8 out of every 100 people will have PTSD at some point during their lifetime. For women, the number is one in every 10. For men, the number changes to four out of 10. That might seem like a low number, but the population of the U.S. is relatively 327.2 million. That means that about 261,760,000 people will be affected by PTSD during their lifetime. For such a high number, there’s still a lot of work to do about PTSD prevention and treatment.
Research has shown that low dopamine function leads to a higher predisposition to PTSD. The GARS® test includes PTSD as a Reward Deficiency Syndrome behavior. The GARS® test uses a very simple cheek swab to analyze a panel of genes for variations that affect the chemical balance in the brain. By taking the GARS® test, a person can understand their genetic predisposition to low dopamine function that can increase the chance of developing the disorder.
MyGenx® also offers restoreGen®, a patented neuro-nutrient. restoreGen® works by balancing serotonin, dopamine, and other chemical messengers in the brain. There are six different formulas tailored to a person’s genetic makeup and variations. Because restoreGen® works to balance dopamine and increase brain health, it has proven to help:
- Reduce addictive cravings
- Optimize brain health
- Increase focus
- Enhance energy levels
- Relieve stress
- Improve overall well-being